Surgical resection of primary tumor

PROCEDURE4 trials

Sponsors

St. Jude Children's Research Hospital, Sun Yat-sen University, Universitätsklinikum Hamburg-Eppendorf, Abramson Cancer Center at Penn Medicine

Conditions

Colorectal Cancer MetastaticEsophageal AdenocarcinomaGastric AdenocarcinomaGastroesophageal Junction AdenocarcinomaHead and Neck CancerNeuroblastoma

Phase 2

Neuroblastoma Protocol 2008: Therapy for Children With Advanced Stage High Risk Neuroblastoma

TerminatedNCT00808899

St. Jude Children's Research HospitalNeuroblastoma

Start: 2008-12-31End: 2009-07-31Updated: 2017-05-30

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

Not yet recruitingNCT07059611

Abramson Cancer Center at Penn MedicineEsophageal Adenocarcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma

Start: 2026-04-01End: 2029-11-01Target: 34Updated: 2026-01-12

Phase 3

Effectiveness Study of Resection of Primary Tumor in Stage IV Colorectal Cancer Patients

Sun Yat-sen UniversityColorectal Cancer Metastatic

Start: 2015-09-30End: 2019-07-31Target: 480Updated: 2017-04-27

Study of Nivolumab Alone or in Combination With Ipilimumab as Immunotherapy vs Standard Follow-up in Surgical Resectable HNSCC After Adjuvant Therapy

Universitätsklinikum Hamburg-EppendorfHead and Neck Cancer

Start: 2018-08-21End: 2024-05-31Target: 276Updated: 2023-05-23

Related Papers

Phase III Study of Nivolumab Alone or Combined with Ipilimumab as Immunotherapy Versus Standard of Care in Resectable Head and Neck Squamous Cell Carcinoma

Future Oncology2020-09-0931 citations

A randomized controlled trial comparing primary tumour resection plus chemotherapy with chemotherapy alone in incurable stage IV colorectal cancer: JCOG1007 (iPACS study)

Japanese Journal of Clinical Oncology2019-11-1944 citations

Multicenter randomized controlled phase III study of nivolumab alone or in combination with ipilimumab as immunotherapy vs standard follow-up in surgical resectable HNSCC after adjuvant therapy.

Journal of Clinical Oncology2019-05-202 citations

Multi-center, randomized, controlled, open-label effectiveness study of primary tumor resection or not in asymptomatic colorectal cancer with unresectable metastatic disease.

Journal of Clinical Oncology2015-05-20